I don’t yet have an answer; it’s an important enough question that I prefer not to shoot from the hip.
Fair enough. (I should add that I don't have a guess myself as I don't feel like I'm enough of an expert in this space to make an educated guess; I do have confidence that MNTA will be able to land a nice FoB deal in due time though with someone. One would think MNTA's success to date with generic Lovenox would enable MNTA to land a nice FoB deal.)